Clinical Trial Update: A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ischemic preconditioning effects of ticagrelor vs. clopidogrel was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Preconditioning

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Ischemic Preconditioning | Phase 4 | Status: TERMINATED